Azzurra Pharmaconutrition Profile
Key Indicators
- Authorised Capital ₹ 1.31 Cr
as on 13-12-2024
- Paid Up Capital ₹ 1.30 Cr
as on 13-12-2024
- Company Age 11 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 13-12-2024
- Satisfied Charges ₹ 9.80 M
as on 13-12-2024
- Revenue -2.99%
(FY 2024)
- Profit -2319.20%
(FY 2024)
- Ebitda 115.35%
(FY 2024)
- Net Worth -13.14%
(FY 2024)
- Total Assets -2.89%
(FY 2024)
About Azzurra Pharmaconutrition
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.31 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹1.00 Cr. The company has closed loans amounting to ₹9.80 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Azzurra Pharmaconutrition Private Limited India is Ritesh Jain as CEO. Rikki Chaudhary, Neelesh Sudeshchandra, and Surya Gupta serve as directors at the Company.
- CIN/LLPIN
U51101HR2014PTC051455
- Company No.
051455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jan 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Azzurra Pharmaconutrition?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritesh Jain  | CEO | 22-Nov-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rikki Chaudhary | Director | 07-Apr-2017 | Current |
| Neelesh Sudeshchandra | Director | 01-Jan-2014 | Current |
| Surya Gupta | Additional Director | 10-Mar-2023 | Current |
Financial Performance of Azzurra Pharmaconutrition.
Azzurra Pharmaconutrition Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 2.99% decrease. The company also saw a substantial fall in profitability, with a 2319.2% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Azzurra Pharmaconutrition?
In 2024, Azzurra Pharmaconutrition had a public holding of 92.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ishaan Management Solutions Private LimitedActive 17 years 8 monthsRikki Chaudhary is a mutual person
- Azzurra Lifesciences Private LimitedActive 8 years 4 months
Neelesh Sudeshchandra and Ritesh Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Aug 2016 | ₹1.00 Cr | Open |
United Bank Of India Creation Date: 29 May 2017 | ₹9.80 M | Satisfied |
How Many Employees Work at Azzurra Pharmaconutrition?
Azzurra Pharmaconutrition has a workforce of 18 employees as of Nov 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Azzurra Pharmaconutrition, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Azzurra Pharmaconutrition's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
